Skip to search
Skip to main content
Back to Search
Start Over
Secondary resectability in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- versus FOLFIRINOX-based induction chemotherapy: Interim results of a randomized phase II AIO trial (NEOLAP).
Authors :
Kunzmann, Volker Martens, Uwe Marc Alguel, Hana Siveke, Jens T. Goekkurt, Eray Pelzer, Uwe Siegler, Gabriele Margareta Hennes, Elke Waldschmidt, Dirk Jakobs, Ralf Ferenczy, Peter Keller, Ralph Boeck, Stefan Hubert Kullmann, Frank Kapp, Markus Germer, Christoph Thomas Kunzmann, Volker Martens, Uwe Marc Alguel, Hana Siveke, Jens T. Goekkurt, Eray Pelzer, Uwe Siegler, Gabriele Margareta Hennes, Elke Waldschmidt, Dirk Jakobs, Ralf Ferenczy, Peter Keller, Ralph Boeck, Stefan Hubert Kullmann, Frank Kapp, Markus Germer, Christoph Thomas
Publication Year :
2018
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1201320163
Document Type :
Electronic Resource